Cargando…
Prolyl Oligopeptidase Regulates Dopamine Transporter Oligomerization and Phosphorylation in a PKC- and ERK-Independent Manner
Prolyl oligopeptidase (PREP) is a serine protease that binds to alpha-synuclein (aSyn) and induces its aggregation. PREP inhibitors have been shown to have beneficial effects in Parkinson’s disease models by enhancing the clearance of aSyn aggregates and modulating striatal dopamine. Additionally, w...
Autores principales: | Julku, Ulrika H., Jäntti, Maria, Svarcbahs, Reinis, Myöhänen, Timo T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916783/ https://www.ncbi.nlm.nih.gov/pubmed/33579026 http://dx.doi.org/10.3390/ijms22041777 |
Ejemplares similares
-
Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo
por: Svarcbahs, Reinis, et al.
Publicado: (2018) -
Nonpeptidic
Oxazole-Based Prolyl Oligopeptidase Ligands
with Disease-Modifying Effects on α-Synuclein Mouse Models
of Parkinson’s Disease
por: Kilpeläinen, Tommi P., et al.
Publicado: (2023) -
Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s disease
por: Kilpeläinen, Tommi, et al.
Publicado: (2019) -
Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington’s disease
por: Norrbacka, Susanna, et al.
Publicado: (2019) -
2-Imidazole as a Substitute for the Electrophilic
Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors
por: Pätsi, Henri T., et al.
Publicado: (2021)